Accel-Heal Technologies Limited is a UK-based company focussed on the development of unique electrical stimulation products to help transform clinical and health economic outcomes in patients with painful and hard-to-heal wounds.
Electrical stimulation is one of the most evidence-based technologies in wound management with five meta analyses and over 30 RCTs published today. It has a real potential to significantly improve outcomes in patients suffering from painful, hard-to-heal wounds.
The challenge has always been how to incorporate what has been perceived as a complex therapy, into frontline clinical practice.
Accel‑Heal, as a pre-programmed, single-use, portable and easy to use electrical stimulation device, has been developed to address this challenge. It is reimbursed and available across all care settings. Please see website for further details and or to request information.